N. İNANÇ Et Al. , "A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors," Turkish Journal of Medical Sciences , vol.53, no.3, pp.731-743, 2023
İNANÇ, N. Et Al. 2023. A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors. Turkish Journal of Medical Sciences , vol.53, no.3 , 731-743.
İNANÇ, N., TERZİOĞLU, M. E., KARABULUT, Y., YILMAZ, Z., TARHAN, F., enecik, m. e., ... sahin, a.(2023). A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors. Turkish Journal of Medical Sciences , vol.53, no.3, 731-743.
İNANÇ, Nevsun Et Al. "A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors," Turkish Journal of Medical Sciences , vol.53, no.3, 731-743, 2023
İNANÇ, Nevsun Et Al. "A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors." Turkish Journal of Medical Sciences , vol.53, no.3, pp.731-743, 2023
İNANÇ, N. Et Al. (2023) . "A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors." Turkish Journal of Medical Sciences , vol.53, no.3, pp.731-743.
@article{article, author={Nevsun İNANÇ Et Al. }, title={A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors}, journal={Turkish Journal of Medical Sciences}, year=2023, pages={731-743} }